|

China Inherited Ventricular Arrhythmias Registry

RECRUITINGSponsored by China National Center for Cardiovascular Diseases
Actively Recruiting
SponsorChina National Center for Cardiovascular Diseases
Started2017-10-24
Est. completion2022-10-24
Eligibility
Age1 Hour – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03880708

Summary

This is an observational, prospective, multi-center registry, aiming at building a risk stratification for malignant inherited ventricular arrhythmias, including Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500 participants will be recruited from 10 centers in China, with clinical data to be abstracted from medical records, and blood samples to be collected for finding related genes and promising risk indicators. The follow-up should be made every 6 months.

Eligibility

Age: 1 Hour – 90 YearsHealthy volunteers accepted
Inclusion Criteria:

* diagnosed as Brugada syndrome(Brs)、Long QT syndrome(LQTS)、Short QT syndrome(SQTS)、Early repolarization syndrome(ERS) or Catecholaminergic polymorphic ventricular tachycardia(CPVT).

Exclusion Criteria:

* patients were enrolled by other clinical trials.

Conditions2

Heart DiseaseVentricular Arrythmia

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.